Venus Remedies Limited (BOM:526953)
1,859.35
-28.30 (-1.50%)
At close: Jun 16, 2026
Venus Remedies Market Cap
Venus Remedies has a market cap or net worth of 24.85 billion as of June 16, 2026. Its market cap has increased by 362.64% in one year.
Market Cap
24.85B
Enterprise Value
23.94B
Revenue
7.70B
Ranking
n/a
PE Ratio
24.18
Stock Price
1,859.35
Market Cap Chart
Since October 19, 2004, Venus Remedies's market cap has increased from 242.83M to 24.85B, an increase of 10,134.99%. That is a compound annual growth rate of 23.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 24.85B | 142.42% |
| Dec 31, 2025 | 10.25B | 139.58% |
| Dec 31, 2024 | 4.28B | -21.14% |
| Dec 29, 2023 | 5.43B | 124.10% |
| Dec 30, 2022 | 2.42B | -55.77% |
| Dec 31, 2021 | 5.48B | 194.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gufic Biosciences | 36.12B |
| Novartis India | 31.98B |
| Unichem Laboratories | 31.41B |
| Morepen Laboratories | 28.70B |
| Kwality Pharmaceuticals | 25.91B |
| Hikal | 23.03B |
| Amrutanjan Health Care | 16.12B |
| Syncom Formulations (India) | 13.43B |